In human cancer, CCND1 is more commonly dysregulated than CCND2 and CCND3. Interestingly, overexpression of cyclin D1 in cancer tissues is closely related to cancer genome instability and resistance of DNA-damaging cancer drugs58, implying a close correlation between CCND1 and the tumor. Here, CCND2 is linked to neoplasm.